ExodusPoint Capital Management, LP - CONSTELLATION PHARMCETICLS I ownership

CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 159 filers reported holding CONSTELLATION PHARMCETICLS I in Q2 2021. The put-call ratio across all filers is 1.34 and the average weighting 0.9%.

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of CONSTELLATION PHARMCETICLS I
ValueSharesWeighting
Q2 2021$1,507,000
+369.5%
44,577
+300.4%
0.02%
+466.7%
Q4 2020$321,000
-70.6%
11,132
-69.4%
0.00%
-89.3%
Q2 2020$1,093,000
+367.1%
36,357
+388.1%
0.03%
+115.4%
Q1 2020$234,0007,4490.01%
Other shareholders
CONSTELLATION PHARMCETICLS I shareholders Q2 2021
NameSharesValueWeighting ↓
Ponoi II Management, LLC 1,574,229$45,338,00033.03%
Ponoi Management, LLC 1,880,623$54,162,00030.99%
VR Adviser, LLC 4,016,873$115,686,00017.01%
Column Group LLC 2,626,631$75,647,0006.86%
COMMODORE CAPITAL LP 423,708$12,203,0006.64%
GREAT POINT PARTNERS LLC 1,024,800$29,514,0004.79%
Venrock Management V, LLC 1,557,276$44,850,0004.23%
Ghost Tree Capital, LLC 625,000$18,000,0004.01%
Euclidean Capital LLC 554,325$15,965,0003.38%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 737,406$21,237,0003.07%
View complete list of CONSTELLATION PHARMCETICLS I shareholders